United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 2 minute read Pharma Industry News Jazz Pharmaceuticals to acquire GW Pharmaceuticals in $7.2bn deal In a significant move within the pharmaceutical industry, Irish biopharma company Jazz Pharmaceuticals has announced an agreement to… bypharmanewsdailyFebruary 3, 2021